BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37418628)

  • 21. Novel positioning from obesity to cancer: FTO, an m
    Chen J; Du B
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):19-29. PubMed ID: 30465076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor.
    Chen B; Ye F; Yu L; Jia G; Huang X; Zhang X; Peng S; Chen K; Wang M; Gong S; Zhang R; Yin J; Li H; Yang Y; Liu H; Zhang J; Zhang H; Zhang A; Jiang H; Luo C; Yang CG
    J Am Chem Soc; 2012 Oct; 134(43):17963-71. PubMed ID: 23045983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. m
    Liu J; Ren D; Du Z; Wang H; Zhang H; Jin Y
    Biochem Biophys Res Commun; 2018 Aug; 502(4):456-464. PubMed ID: 29842885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of the FTO m
    Jeschke J; Collignon E; Al Wardi C; Krayem M; Bizet M; Jia Y; Garaud S; Wimana Z; Calonne E; Hassabi B; Morandini R; Deplus R; Putmans P; Dube G; Singh NK; Koch A; Shostak K; Rizzotto L; Ross RL; Desmedt C; Bareche Y; Rothé F; Lehmann-Che J; Duterque-Coquillaud M; Leroy X; Menschaert G; Teixeira L; Guo M; Limbach PA; Close P; Chariot A; Leucci E; Ghanem G; Yuan BF; Willard-Gallo K; Sotiriou C; Marine JC; Fuks F
    Nat Cancer; 2021 Jun; 2(6):611-628. PubMed ID: 35121941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoplasmic Expression of TP53INP2 Modulated by Demethylase FTO and Mutant NPM1 Promotes Autophagy in Leukemia Cells.
    Huang J; Sun M; Tao Y; Ren J; Peng M; Jing Y; Xiao Q; Yang J; Lin C; Lei L; Yang Z; Zhang L
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fat mass and obesity-associated protein regulates RNA methylation associated with depression-like behavior in mice.
    Liu S; Xiu J; Zhu C; Meng K; Li C; Han R; Du T; Li L; Xu L; Liu R; Zhu W; Shen Y; Xu Q
    Nat Commun; 2021 Nov; 12(1):6937. PubMed ID: 34836959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FTO in cancer: functions, molecular mechanisms, and therapeutic implications.
    Li Y; Su R; Deng X; Chen Y; Chen J
    Trends Cancer; 2022 Jul; 8(7):598-614. PubMed ID: 35346615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FTO (Fat-Mass and Obesity-Associated Protein) Participates in Hemorrhage-Induced Thalamic Pain by Stabilizing Toll-Like Receptor 4 Expression in Thalamic Neurons.
    Fu G; Du S; Huang T; Cao M; Feng X; Wu S; Albik S; Bekker A; Tao YX
    Stroke; 2021 Jul; 52(7):2393-2403. PubMed ID: 34102854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases.
    You Y; Fu Y; Huang M; Shen D; Zhao B; Liu H; Zheng Y; Huang L
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FTO-Dependent N
    Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
    Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability.
    Xu Y; Zhou J; Li L; Yang W; Zhang Z; Zhang K; Ma K; Xie H; Zhang Z; Cai L; Gong Y; Gong K
    Int J Biol Sci; 2022; 18(15):5943-5962. PubMed ID: 36263177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. m
    Wang W; He Y; Zhai LL; Chen LJ; Yao LC; Wu L; Tang ZG; Ning JZ
    Epigenetics; 2022 Dec; 17(12):1738-1752. PubMed ID: 35404184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N6-Methyladenosine Demethylase FTO (Fat Mass and Obesity-Associated Protein) as a Novel Mediator of Statin Effects in Human Endothelial Cells.
    Mo W; Chen Z; Zhang X; Dai G; Ma D; Pan J; Zhang X; Wu G; Fan W
    Arterioscler Thromb Vasc Biol; 2022 May; 42(5):644-658. PubMed ID: 35296150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Specific
    Zhang Y; Li QN; Zhou K; Xu Q; Zhang CY
    Anal Chem; 2020 Oct; 92(20):13936-13944. PubMed ID: 32972135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small-Molecule Inhibitors of the RNA M6A Demethylases FTO Potently Support the Survival of Dopamine Neurons.
    Selberg S; Yu LY; Bondarenko O; Kankuri E; Seli N; Kovaleva V; Herodes K; Saarma M; Karelson M
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of nafamostat mesilate as an inhibitor of the fat mass and obesity-associated protein (FTO) demethylase activity.
    Han X; Wang N; Li J; Wang Y; Wang R; Chang J
    Chem Biol Interact; 2019 Jan; 297():80-84. PubMed ID: 30393114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
    Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
    Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m
    Tan Z; Shi S; Xu J; Liu X; Lei Y; Zhang B; Hua J; Meng Q; Wang W; Yu X; Liang C
    Oncogene; 2022 May; 41(20):2860-2872. PubMed ID: 35422475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging Roles of FTO in Neuropsychiatric Disorders.
    Chang R; Huang Z; Zhao S; Zou J; Li Y; Tan S
    Biomed Res Int; 2022; 2022():2677312. PubMed ID: 35528183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hsa-let-7b-5p Inhibits Proliferation of Human Leukemia THP-1 Cells via FTO/m
    Wu DS; Zheng CF; Zeng YP; Lin J; Chen JL; Shi SJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1873-1879. PubMed ID: 33283713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.